Related Experiment Video
Updated: Jun 10, 2026
06:00
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Cell cycle arrest and apoptosis induction by an anticancer chalcone epoxide
Haiyong Han1, Yu Zhao, Timothy Cuthbertson
1Translational Genomics Research Institute, Phoenix, AZ 85004, USA. hhan@tgen.org
Archiv Der Pharmazie
|August 21, 2010
Summary
Chalcone epoxides show promise as novel pancreatic cancer treatments by inhibiting cancer cell growth and inducing apoptosis. Compound 4a targets microtubules, specifically alkylating beta-tubulin at Cys(354), warranting further investigation.
Area of Science:
- Medicinal Chemistry
- Cancer Biology
- Pharmacology
Background:
- Effective chemotherapeutic agents for pancreatic cancer are urgently needed.
- Chalcone epoxides represent a class of compounds with potential anticancer activity.
Purpose of the Study:
- To evaluate the efficacy of chalcone epoxides against pancreatic cancer cell lines.
- To elucidate the mechanism of action of active chalcone epoxide compounds.
Main Methods:
- In vitro testing of chalcone epoxides on BxPC-3 and MIA PaCa-2 pancreatic cancer cell lines.
- Cell cycle analysis and apoptosis assays to determine the mode of action.
- Investigation of drug-target interactions using tubulin polymerization assays and mass spectrometry.
Main Results:
- Three chalcone epoxides demonstrated significant inhibition of pancreatic cancer cell growth (GI(50) values 5.6–15.8 microM).
- Compound 4a induced G2/M cell cycle arrest and rapid apoptosis in BxPC-3 cells.
- Compound 4a was identified to alkylate beta-tubulin at Cys(354), interfering with microtubule polymerization.
Conclusions:
- Chalcone epoxides, particularly compound 4a, exhibit potent anticancer activity against pancreatic cancer cells.
- The mechanism involves targeting microtubules and inducing cell cycle arrest and apoptosis.
- Chalcone epoxides are promising candidates for further development as pancreatic cancer therapeutics.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.